https://www.selleckchem.com/pr....oducts/vls-1488-kif1
To determine the effects of gonadotropin-releasing hormone analog treatment on final height and body mass index in girls with central precocious puberty. All cases with diagnosis age 8 years constituted group 1 (n=19) and those with ≥8 years constituted group 2 (n=35). There was no significant difference in height standard deviation score, body mass index standard deviation score, bone age/chronologic age, predicted final height at the time of diagnosis, and follow-up between group 1 and group 2. There was no significan
Like
Comment
Share
